We are live on ! Find out more
LAB icon

Standard BioTools
LAB

142 hedge funds and large institutions have $487M invested in Standard BioTools in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 40

5% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 21

1% more funds holding

Funds holding: 141 → 142 (+1)

0.99% less ownership

Funds ownership: 75.76% → 74.78% (-0.99%)

10% less capital invested

Capital invested by funds: $543M → $487M (-$55.5M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

93% less call options, than puts

Call options by funds: $12K | Put options by funds: $178K

Holders
142
Holders Change
+1
Holders Change %
+0.71%
% of All Funds
1.87%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
22
Increased
45
Reduced
40
Closed
21
Calls
$12K
Puts
$178K
Net Calls
-$166K
Net Calls Change
-$147K

Top Buyers

1
MFS
Mirabella Financial Services
United Kingdom
+$5.83M
2
BlackRock
BlackRock
New York
+$4.48M
3
KLP
Kent Lake PR
Puerto Rico
+$3.97M
4
Morgan Stanley
Morgan Stanley
New York
+$2.99M
5
RA
Royce & Associates
New York
+$1.57M

Top Sellers

1
AIM
ARK Investment Management
Florida
-$10.5M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$5.51M
3
NAMA
Nikko Asset Management Americas
New York
-$5.5M
4
Primecap Management
Primecap Management
California
-$4.32M
5
PCMI
Paradigm Capital Management Inc
New York
-$562K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Casdin Capital
New York
$125M – – –
Viking Global Investors
2
Viking Global Investors
Connecticut
$103M – – –
BlackRock
3
BlackRock
New York
$43.5M +$4.48M +2,405,735 +11%
Vanguard Group
4
Vanguard Group
Pennsylvania
$30M -$253K -135,946 -0.8%
Morgan Stanley
5
Morgan Stanley
New York
$29.5M +$2.99M +1,604,884 +11%
Millennium Management
6
Millennium Management
New York
$12.4M +$182K +97,479 +1%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$12.2M +$47.5K +25,504 +0.4%
Sumitomo Mitsui Trust Group
8
Sumitomo Mitsui Trust Group
Japan
$11.6M -$5.51M -2,960,169 -31%
NAMA
9
Nikko Asset Management Americas
New York
$11.5M -$5.5M -2,954,098 -31%
TM
10
Tikvah Management
North Carolina
$11.5M – – –
State Street
11
State Street
Massachusetts
$11M +$1.48M +794,864 +14%
HBWM
12
Hollow Brook Wealth Management
New York
$9.63M -$55.1K -29,570 -0.5%
Neuberger Berman Group
13
Neuberger Berman Group
New York
$8.02M -$279K -149,793 -3%
AIM
14
ARK Investment Management
Florida
$5.82M -$10.5M -5,626,076 -63%
Barclays
15
Barclays
United Kingdom
$5.65M +$4.64K +2,491 +0.1%
MFS
16
Mirabella Financial Services
United Kingdom
$5.48M +$5.83M +3,130,190 New
Northern Trust
17
Northern Trust
Illinois
$5.03M +$454K +243,522 +9%
Charles Schwab
18
Charles Schwab
California
$4.08M -$209K -112,434 -5%
KLP
19
Kent Lake PR
Puerto Rico
$3.73M +$3.97M +2,131,345 New
NFGH
20
Nan Fung Group Holdings
Hong Kong
$3.3M – – –
SPC
21
Slate Path Capital
New York
$2.83M – – –
RA
22
Royce & Associates
New York
$2.55M +$1.57M +840,951 +137%
Goldman Sachs
23
Goldman Sachs
New York
$2.05M +$475K +254,928 +28%
PCP
24
Pacific Capital Partners
$1.75M +$326K +175,000 +21%
JCP
25
Jennifer C. Price
$1.41M -$168K -90,000 -10%
1
2 3 4 5

LAB Hedge Fund Activity: Q4 2024 in Review

142 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2024, worth a combined $487M — down 10% from $543M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new LAB positions and 21 closed out — a net gain of 1 holder — while 45 added to existing stakes and 40 trimmed.

The largest buyer was Mirabella Financial Services, opening a new position worth an estimated $5.83M. The largest seller was ARK Investment Management, cutting an estimated $10.5M.

  • 142 institutional investors held Standard BioTools (LAB) as of Q4 2024, up from 141 in Q3 2024.
  • Funds reported $487M of Standard BioTools stock for Q4 2024, down 10% quarter-over-quarter.
  • 22 funds opened new Standard BioTools positions in Q4 2024 and 21 closed out, a net change of +1 holder.
  • The largest Standard BioTools buyer in Q4 2024 was Mirabella Financial Services, an estimated $5.83M added.
  • The largest Standard BioTools seller in Q4 2024 was ARK Investment Management, an estimated $10.5M sold.

Based on aggregated 13F filings for Q4 2024.